SEC Form 4/A · accession 0001415889-16-005219
Echo Therapeutics, Inc. · ECTE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Shepard M Goldberg
Director
Period of report
Mar 21, 2016
Accepted (ET)
Mar 22, 2016 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001031927
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options (Right to Buy)F2,F1 | $2.00 | Mar 21, 2016 | A | 150,000 | A | — | Mar 21, 2026 | Common Stock | 150,000 | 18,750 | D |
Explanation of responses
- F1On March 21, 2016, the compensation committee, with consent of holder, amended the terms of the option to increase the exercise price and extend the vesting period. As amended, 12.5% of the options vest immediately and 12.5% vest on each of April 1, 2016, July 1,2016, October 1, 2016, January 1, 2017, April 1, 2017, July 1, 2017, and October 1, 2017.
- F2Granted pursuant to the Echo Therapeutics, Inc. 2008 Equity Compensation Plan.